Supreme Court hears arguments in $6 billion Purdue Pharma settlement that would grant immunity to Sacklers

The Supreme Court held its first day of oral arguments in a major bankruptcy case regarding an opioid crisis settlement for Purdue Pharma, the manufacturer of OxyContin.

Justices questioned lawyers for roughly two hours regarding the deal, which would see Purdue release $6 billion to victims of the drug crisis while also granting immunity to the Sackler family, the company's owners. 

The deal, initially approved by a New York court in May, ran into a roadblock when the U.S. Trustee Program...